CDH2 and thyroid gland papillary carcinoma: For instance, miR-31 presents low expression levels in papillary thyroid cancer, while its overexpression promotes vimentin, N-cadherin, p-AKT and p-ERK downregulation, as well as decreased cell migration and invasion [56].